The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vaccine Conjugate-Global Market Insights and Sales Trends 2025
Synopsis
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global Vaccine Conjugate market size is expected to reach US$ 12870 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Conjugate in various end use industries. The expanding demands from the Children and Adult, are propelling Vaccine Conjugate market. Hib Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningococcal Vaccine segment is estimated at % CAGR for the next seven-year period.
North America is the largest supplier of Conjugate Vaccine, with a production market share nearly 65. Europe is the second largest supplier of Conjugate Vaccine, enjoying production market share nearly 26.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Conjugate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Conjugate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Conjugate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Conjugate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Conjugate covered in this report include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic and Chengdu Olymvax Biopharmaceuticals, etc.
The global Vaccine Conjugate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Chengdu Olymvax Biopharmaceuticals
Beijing Minhai Biotechnology
CanSinoBIO
Beijing Xiangrui Biological Products
Global Vaccine Conjugate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Conjugate market, Segment by Type:
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Vaccine Conjugate market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vaccine Conjugate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vaccine Conjugate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global Vaccine Conjugate market size is expected to reach US$ 12870 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Conjugate in various end use industries. The expanding demands from the Children and Adult, are propelling Vaccine Conjugate market. Hib Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningococcal Vaccine segment is estimated at % CAGR for the next seven-year period.
North America is the largest supplier of Conjugate Vaccine, with a production market share nearly 65. Europe is the second largest supplier of Conjugate Vaccine, enjoying production market share nearly 26.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Conjugate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Conjugate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Conjugate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Conjugate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Conjugate covered in this report include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic and Chengdu Olymvax Biopharmaceuticals, etc.
The global Vaccine Conjugate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Chengdu Olymvax Biopharmaceuticals
Beijing Minhai Biotechnology
CanSinoBIO
Beijing Xiangrui Biological Products
Global Vaccine Conjugate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Conjugate market, Segment by Type:
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Vaccine Conjugate market, by Application
Children
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vaccine Conjugate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vaccine Conjugate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vaccine Conjugate Market Overview
1.1 Vaccine Conjugate Product Overview
1.2 Vaccine Conjugate Market Segment by Type
1.2.1 Hib Vaccine
1.2.2 Meningococcal Vaccine
1.2.3 Pneumococcal Vaccine
1.2.4 Others
1.3 Global Vaccine Conjugate Market Size by Type
1.3.1 Global Vaccine Conjugate Market Size Overview by Type (2018-2029)
1.3.2 Global Vaccine Conjugate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vaccine Conjugate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine Conjugate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vaccine Conjugate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vaccine Conjugate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vaccine Conjugate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vaccine Conjugate Sales Breakdown by Type (2018-2023)
2 Global Vaccine Conjugate Market Competition by Company
2.1 Global Top Players by Vaccine Conjugate Sales (2018-2023)
2.2 Global Top Players by Vaccine Conjugate Revenue (2018-2023)
2.3 Global Top Players by Vaccine Conjugate Price (2018-2023)
2.4 Global Top Manufacturers Vaccine Conjugate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine Conjugate Market Competitive Situation and Trends
2.5.1 Vaccine Conjugate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine Conjugate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Conjugate as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccine Conjugate Market
2.8 Key Manufacturers Vaccine Conjugate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine Conjugate Status and Outlook by Region
3.1 Global Vaccine Conjugate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vaccine Conjugate Historic Market Size by Region
3.2.1 Global Vaccine Conjugate Sales in Volume by Region (2018-2023)
3.2.2 Global Vaccine Conjugate Sales in Value by Region (2018-2023)
3.2.3 Global Vaccine Conjugate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vaccine Conjugate Forecasted Market Size by Region
3.3.1 Global Vaccine Conjugate Sales in Volume by Region (2024-2029)
3.3.2 Global Vaccine Conjugate Sales in Value by Region (2024-2029)
3.3.3 Global Vaccine Conjugate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vaccine Conjugate by Application
4.1 Vaccine Conjugate Market Segment by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Vaccine Conjugate Market Size by Application
4.2.1 Global Vaccine Conjugate Market Size Overview by Application (2018-2029)
4.2.2 Global Vaccine Conjugate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vaccine Conjugate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine Conjugate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vaccine Conjugate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vaccine Conjugate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vaccine Conjugate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vaccine Conjugate Sales Breakdown by Application (2018-2023)
5 North America Vaccine Conjugate by Country
5.1 North America Vaccine Conjugate Historic Market Size by Country
5.1.1 North America Vaccine Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vaccine Conjugate Sales in Volume by Country (2018-2023)
5.1.3 North America Vaccine Conjugate Sales in Value by Country (2018-2023)
5.2 North America Vaccine Conjugate Forecasted Market Size by Country
5.2.1 North America Vaccine Conjugate Sales in Volume by Country (2024-2029)
5.2.2 North America Vaccine Conjugate Sales in Value by Country (2024-2029)
6 Europe Vaccine Conjugate by Country
6.1 Europe Vaccine Conjugate Historic Market Size by Country
6.1.1 Europe Vaccine Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vaccine Conjugate Sales in Volume by Country (2018-2023)
6.1.3 Europe Vaccine Conjugate Sales in Value by Country (2018-2023)
6.2 Europe Vaccine Conjugate Forecasted Market Size by Country
6.2.1 Europe Vaccine Conjugate Sales in Volume by Country (2024-2029)
6.2.2 Europe Vaccine Conjugate Sales in Value by Country (2024-2029)
7 Asia-Pacific Vaccine Conjugate by Region
7.1 Asia-Pacific Vaccine Conjugate Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine Conjugate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vaccine Conjugate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vaccine Conjugate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vaccine Conjugate Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine Conjugate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vaccine Conjugate Sales in Value by Region (2024-2029)
8 Latin America Vaccine Conjugate by Country
8.1 Latin America Vaccine Conjugate Historic Market Size by Country
8.1.1 Latin America Vaccine Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vaccine Conjugate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vaccine Conjugate Sales in Value by Country (2018-2023)
8.2 Latin America Vaccine Conjugate Forecasted Market Size by Country
8.2.1 Latin America Vaccine Conjugate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vaccine Conjugate Sales in Value by Country (2024-2029)
9 Middle East and Africa Vaccine Conjugate by Country
9.1 Middle East and Africa Vaccine Conjugate Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vaccine Conjugate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vaccine Conjugate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vaccine Conjugate Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine Conjugate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vaccine Conjugate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Vaccine Conjugate Products Offered
10.1.5 Pfizer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Vaccine Conjugate Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Vaccine Conjugate Products Offered
10.3.5 Sanofi Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Vaccine Conjugate Products Offered
10.4.5 Merck Recent Development
10.5 Walvax Biotechnology
10.5.1 Walvax Biotechnology Company Information
10.5.2 Walvax Biotechnology Introduction and Business Overview
10.5.3 Walvax Biotechnology Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Walvax Biotechnology Vaccine Conjugate Products Offered
10.5.5 Walvax Biotechnology Recent Development
10.6 Royal (Wuxi) Bio-Pharmaceutical
10.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
10.6.2 Royal (Wuxi) Bio-Pharmaceutical Introduction and Business Overview
10.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Products Offered
10.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
10.7 Bharat Biotech
10.7.1 Bharat Biotech Company Information
10.7.2 Bharat Biotech Introduction and Business Overview
10.7.3 Bharat Biotech Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bharat Biotech Vaccine Conjugate Products Offered
10.7.5 Bharat Biotech Recent Development
10.8 Zhifei Biologic
10.8.1 Zhifei Biologic Company Information
10.8.2 Zhifei Biologic Introduction and Business Overview
10.8.3 Zhifei Biologic Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Zhifei Biologic Vaccine Conjugate Products Offered
10.8.5 Zhifei Biologic Recent Development
10.9 Chengdu Olymvax Biopharmaceuticals
10.9.1 Chengdu Olymvax Biopharmaceuticals Company Information
10.9.2 Chengdu Olymvax Biopharmaceuticals Introduction and Business Overview
10.9.3 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Products Offered
10.9.5 Chengdu Olymvax Biopharmaceuticals Recent Development
10.10 Beijing Minhai Biotechnology
10.10.1 Beijing Minhai Biotechnology Company Information
10.10.2 Beijing Minhai Biotechnology Introduction and Business Overview
10.10.3 Beijing Minhai Biotechnology Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Beijing Minhai Biotechnology Vaccine Conjugate Products Offered
10.10.5 Beijing Minhai Biotechnology Recent Development
10.11 CanSinoBIO
10.11.1 CanSinoBIO Company Information
10.11.2 CanSinoBIO Introduction and Business Overview
10.11.3 CanSinoBIO Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.11.4 CanSinoBIO Vaccine Conjugate Products Offered
10.11.5 CanSinoBIO Recent Development
10.12 Beijing Xiangrui Biological Products
10.12.1 Beijing Xiangrui Biological Products Company Information
10.12.2 Beijing Xiangrui Biological Products Introduction and Business Overview
10.12.3 Beijing Xiangrui Biological Products Vaccine Conjugate Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Beijing Xiangrui Biological Products Vaccine Conjugate Products Offered
10.12.5 Beijing Xiangrui Biological Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine Conjugate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine Conjugate Industrial Chain Analysis
11.4 Vaccine Conjugate Market Dynamics
11.4.1 Vaccine Conjugate Industry Trends
11.4.2 Vaccine Conjugate Market Drivers
11.4.3 Vaccine Conjugate Market Challenges
11.4.4 Vaccine Conjugate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine Conjugate Distributors
12.3 Vaccine Conjugate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
